Compile Data Set for Download or QSAR
maximum 50k data
Found 63 Enz. Inhib. hit(s) with all data for entry = 3141
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389651((E)-6-(4-(4-(dimethylamino)but-2-enoyl)piperazin-1...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM392799(2-(4-phenoxyphenyl)-6-(4-(vinylsulfonyl)piperazin-...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389681(6-(1-acryloylpiperidin-4-yl)-2-(4-(phenylcarbamoyl...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389680(6-(4-acryloylpiperazin-1-yl)-2-(4-((4,4-difluorocy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389679((E)-1-(1-(2-cyanobut-2-enoyl)azetidin-3-yl)-3-(4-p...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389678(6-(1-acryloylpiperidin-4-yl)-2-(4-(hydroxy(phenyl)...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389676(5-(4-acryloylpiperazin-1-yl)-4′-phenoxybiphe...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389675(5-(1-acryloylpiperidin-4-yl)-4′-phenoxybiphe...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389674(2-(1-acryloylpiperidin-3-yl)-5-(4-phenoxyphenyl)ox...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389673(2-(1-acryloylpiperidin-4-yl)-4-(4-phenoxyphenyl)th...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389672(2-(4-acryloylpiperazin-1-yl)-4-(4-phenoxyphenyl)th...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389671(2-(1-acryloylpiperidin-4-yl)-5-(4-phenoxyphenyl)th...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389630(6-(3-acrylamidophenyl)-2-(4-phenoxyphenyl)nicotina...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389631(6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)ni...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389632(6-(4-acryloylpiperazin-1-yl)-2-(4-phenoxyphenyl)ni...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389634(6-(4-acrylamidophenyl)-2-(4-phenoxyphenyl)nicotina...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389635(6-(1-acryloylpiperidin-3-yl)-2-(4-phenoxyphenyl)ni...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389636(6-(3-acrylamidopyrrolidin-1-yl)-2-(4-phenoxyphenyl...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389637(1-(1-acryloylpiperidin-3-yl)-3-(4-phenoxyphenyl)-1...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM303544(US10138229, Example 55 | US10875852, Example 55 | ...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389641(1-(1-acryloylpyrrolidin-3-yl)-3-(4-phenoxyphenyl)-...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389642(1-(1-acryloylazetidin-3-yl)-3-(4-phenoxyphenyl)-1H...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389643(1-(4-acrylamidophenyl)-3-(4-phenoxyphenyl)-1H-pyra...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389644(1-(3-aminophenyl)-3-(4-phenoxyphenyl)-1H-pyrazole-...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389645(1-(3-acrylamidophenyl)-3-(4-phenoxyphenyl)-1H-pyra...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389646((S)-1-(1-acryloylpyrrolidin-3-yl)-3-(4-phenoxyphen...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389647((R)-1-(1-acryloylpyrrolidin-3-yl)-3-(4-phenoxyphen...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389648(2-(1-acryloylpiperidin-4-yl)-4-(4-phenoxyphenyl)py...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389649(2-(1-acryloylpyrrolidin-3-yl)-4-(4-phenoxyphenyl)p...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389633(6-(1-acryloylpyrrolidin-3-yl)-2-(4-phenoxyphenyl)n...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM390425(2-(4-phenoxyphenyl)-6-(1-(vinylsulfonyl)piperidin-...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389652(6-(4-acryloylpiperazin-1-yl)-2-(4-phenoxyphenyl)py...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389653(6-(4-acryloylpiperazin-1-yl)-2-(4-(cyclohexyloxy)p...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389654(6-(4-acryloylpiperazin-1-yl)-2-(3-methoxy-4-methyl...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389655(6-(4-acryloylpiperazin-1-yl)-2-(4-(pyridin-2-yloxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389656(1-(1-(4-(dimethylamino)but-2-enoyl)pyrrolidin-3-yl...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389657(6-(4-acryloylpiperazin-1-yl)-2-(4-(3-fluorophenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389658(6-(4-acryloylpiperazin-1-yl)-2-(3-fluoro-4-phenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389659(6-(4-acryloylpiperazin-1-yl)-2-(4-(4-fluorophenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389660(6-(4-acryloylpiperazin-1-yl)-2-(4-(2-fluorophenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389661(6-(4-acryloylpiperazin-1-yl)-2-(2-fluoro-4-phenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389662(2-(1-acryloylpiperidin-3-yl)-4-(4-phenoxyphenyl)th...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389663(2-(1-acryloylpyrrolidin-3-yl)-4-(4-phenoxyphenyl)t...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389664(2-(1-acryloylpiperidin-3-yl)-4-(4-phenoxyphenyl)ox...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389665(2-(1-acryloylpyrrolidin-3-yl)-4-(4-phenoxyphenyl)o...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389666(2-(1-acryloylpyrrolidin-3-yl)-5-(4-phenoxyphenyl)t...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389667(2-(1-acryloylpiperidin-3-yl)-5-(4-phenoxyphenyl)th...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389668(2-(1-acryloylpiperidin-4-yl)-4-(4-phenoxyphenyl)ox...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Guangzhou Innocare Pharma Tech

US Patent
LigandPNGBDBM389669(2-(4-acryloylpiperazin-1-yl)-N-methyl-4-(4-phenoxy...)
Affinity DataIC50: <500nMAssay Description:1× and 2× assay buffer were made at first. BTK kinase was diluted with 1× assay buffer but substrate was diluted with 2× assay buffer. 1 ul of dilute...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 63 total ) | Next | Last >>
Jump to: